[pending] CARBOXYMETHYLCELLULOSE SODIUM (CARBOXYMETHYLCELLULOSE SODIUM)
Pending LLM rewrite. Source: FDA_DRUG D-0406-2025.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
cGMP deviations and lack of assurance of sterility.
The recalled product
- Product
- CARBOXYMETHYLCELLULOSE SODIUM (CARBOXYMETHYLCELLULOSE SODIUM)
- Brand
- CARBOXYMETHYLCELLULOSE SODIUM
- Manufacturer
- BRS Analytical Services, LLC
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot
- expiry: Lot 103
- exp 4/26/25
- Lot 104
- exp 5/03/25
- Lot 108
- exp 6/29/25
- Lot 109
- exp 7/18/25
- Lot 110
- exp 8/17/25
- Lot 111
- exp 8/22/25
- Lot 112
- exp 8/27/25
- Lot 113
- exp 9/18/25
- Lot 125
- exp 10/23/25
- Lot 130
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CARBOXYMETHYLCELLULOSE SODIUM
- ModerateCarboxymethylcellulose sodium eye drops recalled for label mix-up
FDA (Drugs) · 2025-01-08
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27